Cholangiocarcinoma News

Videos

A View to the Future of Cholangiocarcinoma Therapy

Mechanisms of Resistance to FGFR Inhibitors
Videos — October 21, 2021
Drs Javle, Bañales, and Hollebecque discuss the innate and acquired resistance pathways to FGFR inhibitors in cholangiocarcinoma and how these pathways can have important effects on clinical outcomes. They also look ahead to ongoing clinical trials evaluating next-generation FGFR inhibitors that may be able to overcome resistance mechanisms and improve progression-free and overall survival in cholangiocarcinoma.
Read More

Key Abstracts Presented at the European Society for Medical Oncology (ESMO) 2021 Annual Meeting
Videos — September 29, 2021
Richard Kim, MD, from the Moffitt Cancer Center, University of South Florida College of Medicine, provides expert commentary on key abstracts and posters presented at the 2021 annual meeting of the European Society for Medical Oncology. Dr Kim will highlight new data from 11 presentations on interventional modalities for patients with cholangiocarcinoma.
Read More

The Role of Liquid Biopsy in CCA

Combination Therapy with FGFR Inhibitors in CCA

Key Abstracts Presented at the Americas Hepato-Pancreato-Biliary Association (AHPBA) 2021 Annual Meeting
Videos — August 9, 2021
Flavio G. Rocha, MD, FACS, FSSO, from the Knight Cancer Institute, Oregon Health & Science University, provides expert commentary on key abstracts and posters presented at the 2021 annual meeting of the Americas Hepato-Pancreato-Biliary Association. Dr Rocha will highlight new data from 10 presentations on interventional modalities for patients with cholangiocarcinoma.
Read More

Evolution in Biomarker Testing in CCA
Videos — July 21, 2021
Using next-generation sequencing to detect FGFR fusion partners and co-mutations to improve efficacy in treating CCA
Read More

Assessing Quality of Life in CCA Patients Treated with FGFR Inhibitors

CCA Summit Live from ASCO 2021
Videos — June 9, 2021
On June 8, 2021, Dr Mitesh Borad, Associate Professor of Medicine at the Mayo Clinic in Phoenix, AZ, and a member of the Cholangiocarcinoma Summit Program Steering Committee, presented the top 15 abstracts on the management of cholangiocarcinoma and biliary tract cancer at ASCO 2021.
Read More

Managing Adverse Events in CCA Patients Treated with FGFR Inhibitors

Page 3 of 5


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: